TY - JOUR
T1 - Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis
AU - Horita, Yasuhiro
AU - Takii, Takemasa
AU - Chiba, Taku
AU - Kuroishi, Ryuji
AU - Maeda, Yasuhiro
AU - Kurono, Yukihisa
AU - Inagaki, Emi
AU - Nishimura, Kenji
AU - Yamamoto, Yoshifumi
AU - Abe, Chiyoji
AU - Mori, Masami
AU - Onozaki, Kikuo
N1 - Funding Information:
This work was supported in part by Grant-in-Aid for Scientific Research on (C) from Japan Society for the Promotion of Sciences , a grant for Research on Publicly Essential Drugs and Medical Devices, No. KHC1021, from the Japan Health Sciences Foundation , and a Grant-in-Aid for Scientific Research on the U.S.-Japan Cooperative Medical Sciences Program, Ministry of Health, Labour and Welfare, Japan.
PY - 2009
Y1 - 2009
N2 - A series of sugar derivatives (1-13) were synthesized and evaluated for antibacterial activity against Mycobacterium tuberculosis (MTB), especially multi-drug resistant (MDR) MTB, and the structure-activity relationships of these compounds were studied. The results showed that the compound OCT313 (2-acetamido-2deoxy-β-d-glucopyranosyl N,N-dimethyldithiocarbamate) (4) exhibited significant in vitro bactericidal activity, and that the dithiocarbamate group at C-1 position of the glucopyranoside ring was requisite for the antibacterial activity.
AB - A series of sugar derivatives (1-13) were synthesized and evaluated for antibacterial activity against Mycobacterium tuberculosis (MTB), especially multi-drug resistant (MDR) MTB, and the structure-activity relationships of these compounds were studied. The results showed that the compound OCT313 (2-acetamido-2deoxy-β-d-glucopyranosyl N,N-dimethyldithiocarbamate) (4) exhibited significant in vitro bactericidal activity, and that the dithiocarbamate group at C-1 position of the glucopyranoside ring was requisite for the antibacterial activity.
UR - http://www.scopus.com/inward/record.url?scp=71049134889&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=71049134889&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2009.09.095
DO - 10.1016/j.bmcl.2009.09.095
M3 - Article
C2 - 19828313
AN - SCOPUS:71049134889
SN - 0960-894X
VL - 19
SP - 6313
EP - 6316
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 22
ER -